Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OPKO Health Inc. M&A Activity 2021

May 24, 2021

6963_rns_2021-05-24_75133e3e-a00f-47b6-b8bb-2157895427a7.htm

M&A Activity

Open in viewer

Opens in your device viewer

OPKO Health Reports Transfer of Licensed Rights to RAYALDEE� in Japan to Vifor����� ���� �� ���� �� ����� ������ ������ ���� false

����� ���', ���� 2 380
OPKO HEALTH, INC
Corporation no: 2279206 10018
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 24/05/2021
www.isa.gov.il www.tase.co.il Reference: 2021-02-089208 Time of broadcast: 18:37 18:37

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onOPKO Health Reports Transfer of Licensed Rights to RAYALDEE� in Japan to Vifor ����� ���� �� ���� �� ����� ������ ������ ����

20210524PR_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ GSM Date of revision of form structure: 04/05/2021
Address: Ashlegan 16 , Kiryat Gat 8211804   Israel , Tel: 08-9300051 , Fax: 08-9543101
E-mail address: [email protected]   Company site: Www.Opko.Com
Previous names of reporting entity:
Name of the Signatory: Benor Sharon Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Golda Meir 7 , Nes-Ziona 7414002 Telephone: 08-9300051 Facsimile: 08-9300091 E-mail: [email protected] 1